Skip to main content
. 2023 May 31;120(21-22):365–372. doi: 10.3238/arztebl.m2023.0066

eTable 1. Compilation of available data on the epidemiology of medial sclerosis in different populations (selection)*.

Population Number of subjects Prevalence of medial sclerosis (%) Methods References
Pelvis/legs
General population 4 735 10 (total)
13.3 (men)
6.9 (women)
0.6 (total)
1.1 (men)
0.5 (women)
0.6 (total)
ABI >1.3




ABI >1.5




>260 mm Hg
(e1)
48 294 2.5 (total)
2.8 (men)
2.2 (women)
ABI >1.4 (e2)
6 647 1.6 (total) ABI ≥ 1.4 or noncompressible (e3)
Cardiovascular disease or high risk 718 25 (total)
8.7 (total)
CT (extremities)
ABI >1.4
(e4)
Diabetes mellitus 623 9 (total) BP difference >50 mm Hg or noncompressible (e5)
662 4.45 (total) ABI ≥ 1.3 (e6)
1 059 41.5 (total) Radiography (plain)
Femur
(e7)
133 17.3 (total)
23 (men)
11 (women)
Radiography (plain)
Femur
(e8)
250

20.4 (total) vs control 8
23.6 (total) vs control 8.8
Radiography (plain)
Knee
Feet
(e9)
Cardiovascular disease or high risk and diabetes
Risk






Diabetes mellitus





520
198


34
23.1

34.2
30.8
CT (dominant medial pattern)
Femur
Lower leg
Femur
Lower leg
(e10)
Severe chronic kidney disease 202 26.7 (total) Radiography (plain)
Pelvis and femur
(e11)
Peripheral arterial occlusive disease (PAOD) 204

75
93.5
80.5
57.9
85
78.6
CT (full body)
Foot
Lower leg
Femur
Pelvis
Abdominal aorta
Thoracic aorta
(e12)
PAOD (critical chronic leg ischemia or amputation) 1 413 24.8 ABI > 1.4 (e13)
Suspected stroke
Internal carotid artery, intracranial 1 132 46.9 CT (head) (e14)

* The considerable differences in reported data presumably reflect different testing methods (ABI, radiography, CT), different cut-off values for ABI (1.3; 1.4; 1.5; noncompressible, pressure difference, >260 mm Hg), and different age distributions in the studied populations.

ABI, ankle-brachial index; CT, computed tomography; PAOD, peripheral arterial occlusive disease; vs, versus